Next Generation TIL-Based Therapeutics2021-02-12T00:29:14+00:00

Project Description

Tumor infiltrating lymphocytes or TILs are immune system cells that have penetrated the tumor.  Tailored’s technology leverages proprietary next generation methods to identify tumor-reactive T-cells and therefore develop a cell therapy product comprised of the best tumor fighters.  Advanced genomics and single cell analysis capabilities have produced important insights into proprietary markers and genomic signature characteristic of tumor-fighting T-cells found within TIL.